Sufentanil Citrate

CAS 60561-17-3 7 current records 1 historicalSmall Molecule

Who holds supplier records for Sufentanil Citrate? 7 organisations hold a current record for Sufentanil Citrate: an active US FDA Type II Drug Master File or a CEP. A further 1 organisation has only historical (inactive) DMF filings. 6 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: United States (1), United Kingdom (1), Slovakia (1), Belgium (1) and 2 other countries (2); not recorded for 1.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Sufentanil Citrate: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/sufentanil-citrate

Reading the evidence

  • 7 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • 5 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (7)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Sufentanil Citrate. Country is the organisation's recorded country, not necessarily the manufacturing site.

Need Sufentanil Citrate sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (6)

Certificates of Suitability on the EDQM register for Sufentanil Citrate, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 8 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
YICHANG HUMANWELL PHARMACEUTICAL CO., LTD. YichangCN
CEP 2026-011 - Rev 00
Sufentanil citrate
Nov 2026Inspected Jul 2026
Hungary
MACFARLAN SMITH LIMITED EdinburghGB
CEP 2005-162 - Rev 03
Sufentanil citrate
Aug 2026—
KERN PHARMA, S.L. TerrassaES
CEP 2020-088 - Rev 02
Sufentanil citrate
Jun 2026Inspected Sept 2024
Spain
HAMELN RDS S.R.O. ModraSK
CEP 2022-096 - Rev 04
Sufentanil citrate
Sept 2025Inspected Mar 2026
Slovakia
SPECGX LLC Webster GrovesUS
CEP 2017-095 - Rev 01
Sufentanil citrate
May 2024—
JANSSEN PHARMACEUTICA NV BeerseBE
R1-CEP 1998-116 - Rev 07
Sufentanil citrate
Jul 2022—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (1)

Organisations whose Type II DMFs for Sufentanil Citrate are no longer active. These show a past filing, not current supply.

Show all 1 historical record

Other forms of this substance

A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:

Overview

Sufentanil Citrate is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1201163).

Chemical identity

IUPAC name
2-hydroxypropane-1,2,3-tricarboxylic acid;N-[4-(methoxymethyl)-1-(2-thiophen-2-ylethyl)piperidin-4-yl]-N-phenylpropanamide
Canonical SMILES
CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC3=CC=CS3)COC.C(C(=O)O)C(CC(=O)O)(C(=O)O)O
InChIKey
OJCZPLDERGDQRJ-UHFFFAOYSA-N
Synonyms
Dsuvia, Dzuveo, R 33800, R-33800, Sufenta, Sufental, Sufentanil citrate, Sufentanil citrate cii, Sufenta preservative free, Zalviso, Fentatienil, RefChem:58797

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Opioid Agonist
Mechanism of action
Full Opioid Agonists

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Sufentanil Citrate?

7 organisations hold an active US FDA Type II Drug Master File or a CEP for Sufentanil Citrate: SPECGX LLC (United States), VERANOVA LP (United Kingdom), hameln rds s.r.o. (Slovakia), Janssen Pharmaceutica NV (Belgium), Kern Pharma, S.L. (Spain), MACFARLAN SMITH LTD and YICHANG HUMANWELL PHARMACEUTICAL CO LTD (China). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Sufentanil Citrate Drug Master Files are active?

SPECGX LLC (DMF 30985, 14505) and VERANOVA LP (DMF 9399). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Sufentanil Citrate records mean?

1 organisation has only inactive Type II DMFs for Sufentanil Citrate. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Sufentanil Citrate have a European Certificate of Suitability?

Yes. 6 organisations hold a valid CEP for Sufentanil Citrate on the EDQM register, including YICHANG HUMANWELL PHARMACEUTICAL CO., LTD. Yichang (CN), MACFARLAN SMITH LIMITED Edinburgh (GB), KERN PHARMA, S.L. Terrassa (ES), HAMELN RDS S.R.O. Modra (SK), SPECGX LLC Webster Groves (US) and JANSSEN PHARMACEUTICA NV Beerse (BE). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

How do I qualify a Sufentanil Citrate supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Sufentanil Citrate?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.